US › Healthcare

INVO Fertility, Inc. (IVF)

US · Healthcare · Medical Devices

$0.56-5.58%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$2.2M

Revenue YoY

+16.7%

Net profit

$888,740

EPS

$0.35

EPS estimate

$-5.60

Net margin

40.9%

EPS came in at 0.35 against a street estimate of -5.60 — a beat of 106.2%.

Key statistics

Market cap

$2.9M

P/E

0.0

Forward P/E

0.0

P/B

0.16

Book value

$7.01

EPS (TTM)

$127.95

52-week high

$84.40

52-week low

$0.58

50-day MA

$0.99

200-day MA

$2.55

Analyst view

Analysts rate INVO Fertility, Inc. a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $20.00.

Shareholding

Insiders

0.90%

Institutions

12.92%

Largest institutional holders

Fund	Stake
Virtu Financial LLC	1.37%
Scientech Research LLC	0.70%
StoneX Group Inc	0.34%
Susquehanna International Group, LLP	0.25%
Tower Research Capital LLC	0.18%
SBI Securities Co Ltd	0.00%
Caitong International Asset Management Co., Limited.	0.00%
Integrated Wealth Concepts LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for INVO Fertility, Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.